Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02959827 · ClinicalTrials.gov registry record
Iodinated Contrast Agents and Risk of Hypothyroidism in Young Children in the United States
A clinical trial, sponsored by Bayer.
- Completed
- Registry status
- 2,320
- Enrollment target
NCT02959827 is a clinical trial that has completed, run by Bayer. The registered enrollment target is 2,320 participants.
The verdict
NCT02959827 has completed, sponsored by Bayer.
- COMPLETED
- Registry status
- 2,320 participants
- Enrollment target
Study Summary
This study will estimate the incidence of hypothyroidism in a pediatric population of children under age 4, based on data from the US-based Kaiser Permanente Northern California database, which were exposed to iodinated contrast agent through having a diagnostic procedure.
Interventions
- DRUG Iodinated contrast agents
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,320 participants |
| Start Date | 2016-10-15 |
| Est. Completion | 2017-06-15 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02959827
The ClinicalTrials.gov registry entry for NCT02959827 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 2,320 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Bayer, which has 591 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Iodinated contrast agents is the first listed.
NCT02959827 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02959827 about?
NCT02959827 is a clinical study titled "Iodinated Contrast Agents and Risk of Hypothyroidism in Young Children in the United States". This study will estimate the incidence of hypothyroidism in a pediatric population of children under age 4, based on data from the US-based Kaiser Permanente Northern California database, which were exposed to iodinated contrast agent through having a diagnostic procedure.
What is the current status of trial NCT02959827?
This trial is currently completed. The enrollment target is 2,320 participants. The study started on 2016-10-15. Estimated completion is 2017-06-15.
What interventions are being tested in trial NCT02959827?
The interventions under investigation include: Iodinated contrast agents (DRUG).
Who is sponsoring clinical trial NCT02959827?
This trial is sponsored by Bayer, which has 591 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.